Evidence supporting the use of: Anthocyanins
For the health condition: Arteriosclerosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Anthocyanins are a class of flavonoid compounds found in many fruits and vegetables, particularly in berries, red cabbage, and purple corn. There is a growing body of scientific evidence suggesting that anthocyanins may have beneficial effects in the prevention and management of arteriosclerosis (also known as atherosclerosis), a condition characterized by the thickening and hardening of arterial walls due to plaque buildup. The potential mechanisms involve their antioxidant, anti-inflammatory, and lipid-lowering properties.

Several animal studies and small human clinical trials have indicated that anthocyanins can reduce oxidative stress and inflammation—two key contributors to arteriosclerosis. For example, anthocyanin supplementation has been shown to decrease LDL cholesterol oxidation, inhibit the expression of adhesion molecules involved in plaque formation, and improve endothelial function. A meta-analysis of randomized controlled trials also found that anthocyanin supplementation can lead to modest but statistically significant reductions in LDL cholesterol and improvements in HDL cholesterol.

However, while the evidence is promising, it is not yet conclusive. Most human studies are limited in size, duration, or methodological quality. Large-scale, long-term clinical trials are still needed to fully confirm the effectiveness of anthocyanins in the treatment or prevention of arteriosclerosis. Therefore, while there is clear scientific interest and preliminary support (hence a rating of 3), anthocyanins should be considered a complementary rather than a primary therapy for arteriosclerosis at this time.

More about anthocyanins
More about Arteriosclerosis

Products containing anthocyanins